Yasho Industries Ltd

- The company recently completed a capital raise of INR125 crores through a preferential allotment. - Of this, INR50 crores is allocated for debt repayment, improving the balance sheet. - The remaining INR75 crores are retained for working capital needs currently and planned future expansion in FY '26. - There is no specific mention of any new fundraising through debt or equity beyond this INR125 crore raise. - The company aims to reduce its debt-to-EBITDA ratio to around 3.5x by FY '26, indicating a focus on prudent financial management. - No immediate plans for additional fundraising were stated during the call, but future expansion capex may require further funding depending on business growth.

- Post recent INR125 crores fundraising, INR50 crores will be used for debt repayment; remaining INR75 crores retained for working capital and future expansion (Q11-12). - Planned capex in FY '26 focused on new products and new chemistry in the industrial segment (Q10-11). - Expansion linked to new product launches expected to trigger once plant utilization surpasses 70%, with faster brownfield capex possible (Q10). - Upgrade planned for R&D facility within next few months to support innovation (Q4). - Future capex aimed at increasing utilization and capacity at Pakhajan plant over next 3-4 years, including a second phase of expansion (Q7-8).

- Revenue for FY '25 expected around INR 650-670 crores with 15% YoY growth. - FY '26 revenue guidance is INR 950-1,000 crores with EBITDA margin 17%-19%. - FY '27 revenue projected at INR 1,250-1,300 crores with EBITDA margin around 18%. - Volume growth in Q4 expected at 30%-35%. - Pakhajan plant utilization to reach 85%-90% by the last quarter of FY '26. - Ramp-up delayed by about 2 quarters due to customer approvals and RFQ delays; expected to normalize by March 2025. - Expansion plans for new molecules and products primarily in industrial chemical segment. - Long-term growth supported by increased utilization of new facility and new product launches. - U.S. subsidiary revenue to begin from March 2025, supporting international market expansion.

- Yasho Industries expects revenue for FY '26 in the range of INR 950 to 1,000 crores, increasing to INR 1,250 to 1,300 crores in FY '27 with full plant utilization. - EBITDA margin guidance for FY '26 and FY '27 is maintained at 17% to 19%, targeting a sustainable gross margin of 38%-39%. - EBITDA run rate at peak utilization is projected around INR 220-240 crores. - Debt-to-EBITDA ratio is targeted to be reduced to approximately 3.5x by FY '26. - The company plans to use funds raised (INR125 crores) partly for debt repayment and working capital, with expansion capex starting in FY '26 aiming for new product lines in the industrial chemical segment. - Ramp-up at the Pakhajan plant is expected to reach 85%-90% utilization by Q4 FY '26. - Long-term expansion and operational efficiencies are expected to support margin improvement and sustained profit growth.

- Some customer RFQs (Request for Quotations) were delayed or pending, affecting the ramp-up at the Pakhajan plant; these RFQs are now expected around July-August 2025. - A couple of customers were not ready to reorder or enter long-term contracts, which slowed capacity utilization. - Customer approvals for products are ongoing; out of 10 customers, six have given full approval, and four are still under evaluation. - Inventory levels were high (INR 100-160 crores) due to put-on-hold orders but expected to normalize by March 2025 with new order traction. - New subsidiary in the U.S. will start generating revenue from March 2025, supporting better market reach. - Current orderbook status not explicitly quantified, but growth and order ramp-up are anticipated to improve from Q4 FY '25 onwards, with volume growth guidance of 30-35%.